2006
DOI: 10.1016/j.expneurol.2006.02.005
|View full text |Cite
|
Sign up to set email alerts
|

Fluoxetine rescues deficient neurogenesis in hippocampus of the Ts65Dn mouse model for Down syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

15
114
2
1

Year Published

2006
2006
2017
2017

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 136 publications
(132 citation statements)
references
References 26 publications
15
114
2
1
Order By: Relevance
“…At postnatal day 2 cell proliferation in Ts65Dn mice, assessed 2 hours after single injection of bromodeoxyuridine (BrdU) was significantly reduced (Contestabile et al, 2007); similar results were revealed at postnatal day 15 (Bianchi et al, 2010). However in young adult Ts65Dn mice the results are conflicting (Clark et al, 2006;Rueda et al, 2005). Similar procedures in young (3-5 months) Ts65Dn mice shows no difference in hippocampal cell proliferation and survival (Rueda et al, 2005).…”
Section: Neurogenesis In Mouse Models Of Dssupporting
confidence: 61%
See 2 more Smart Citations
“…At postnatal day 2 cell proliferation in Ts65Dn mice, assessed 2 hours after single injection of bromodeoxyuridine (BrdU) was significantly reduced (Contestabile et al, 2007); similar results were revealed at postnatal day 15 (Bianchi et al, 2010). However in young adult Ts65Dn mice the results are conflicting (Clark et al, 2006;Rueda et al, 2005). Similar procedures in young (3-5 months) Ts65Dn mice shows no difference in hippocampal cell proliferation and survival (Rueda et al, 2005).…”
Section: Neurogenesis In Mouse Models Of Dssupporting
confidence: 61%
“…However, in aged (13-15 months) Ts65Dn mice, cell proliferation in the hippocampus (Rueda et al, 2005) and in the subventricular zone (Bianchi et al, 2010) were significantly reduced. Finally, Clark et al (2006) found a difference in DG neurogenesis in young (2-5 months) Ts65Dn mice. It seems that genetic dissections of mouse partial trisomy 16 (Ts65Dn model) did not restore reduced neurogenesis.…”
Section: Neurogenesis In Mouse Models Of Dsmentioning
confidence: 99%
See 1 more Smart Citation
“…146,147 The most intensively studied mouse model of DS is the Ts65Dn line, 148 which summarizes the main hallmarks of the DS phenotype, including characteristic craniofacial abnormalities, impaired spatial and non-spatial learning abilities and attention deficits. [149][150][151][152][153][154] At the cellular level, Ts65Dn mice have a reduced number of hippocampal and cerebellar neurons, 155,156 impaired neurogenesis in the dentate gyrus of the hippocampus in both young and aged adults 157,158 and a prominent reduction in dendritic branching in several brain regions, accompanied by alterations in spine size and shape. 159 It is noteworthy that DS is also associated with reduced hippocampal neurogenesis 160 and volume 161 in humans.…”
Section: Impact Of Ee On the Brain L Baroncelli Et Almentioning
confidence: 99%
“…Integration of knowledge about protein interactions and the hypotheses produced by computational modeling regarding pathway perturbation can be tested in mouse models. These mouse models can be further manipulated by genetic and pharmacological means to verify candidate [31][32][33][34] Treatment with fluoxetine, NGF, an agonist of sonic hedgehog, and estrogen, respectively, were shown to provide improvements. A systematic biological approach will define pathway perturbations and identify new, more effective targets for development of therapeutics.…”
Section: Introductionmentioning
confidence: 99%